Identify fetal red blood cells in maternal blood for the diagnostics of Rhesus D hemolytic disease of the newborn (RhD HDN)
Project Lead(s): Yu Sun
Yu Sun at the University of Toronto is developing and testing an easy-to-use automated instrument for counting fetal and maternal red blood cells to enable proper dosing of RhoGAM for the treatment of Hemolytic Disease of the Fetus and Newborn. Clinical validation of the instrument will be conducted with partners in Egypt. The innovation will make RhoGAM more widely accessible in African countries by minimizing the financial burden of overdosing.